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Background:  Coronary artery anuerysms are often found during cardiac catheterization, however, severe dilation of the three main 
coronary arteries is often found only in children with Kawasaki’s Disease. The long and short term management of partially thrombosed 
aneurysms is unknown.
case:  An 80 y/o male presented to the ER with chest pain and an EKG concerning for acute posterior ST elevation MI. He was 
hypotensive and tachycardic and emergently taken to the cardiac catheterization laboratory where he was noted to have severe aneurisms 
of all three coronary arteries with a heavy burden of thrombus in his left anterior descending, left circumflex and right coronary artery. A 
balloon pump could not be placed due to aortic and iliac artery tortuosity. He was deemed not a surgical revascularization candidate. He 
further deteriorated and required increasing doses of pressors.
decision Making:  After consultation among interventional cardiology, cardiothoracic surgery and the family, intracoronary alteplase was 
delivered in 10 mg boluses, three times. His hemodynamics improved and he was weaned from pressors. His troponin peaked at 22. An 
echocardiogram the next day showed an EF of 50-55%. The patient was discharged on aspirin and clopidogrel. At follow up 18 months 
later the patient remains symptom free.
conclusion:  Aneurysms of all three coronary arteries with thrombosis and shock is extremely rare. Intra coronary alteplase can be 
considered but there is a lack of data to guide dose and timing.
